← Leaderboards
Jose A. Cancelas
Cincinnati Childrens Hosp Med Ctr
$9,659,208
Attributed
$16,907,750
Total exposure
13
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,907,750 · 13
By mechanism
R01$8,424,496 · 5
U01$4,070,486 · 1
R44$2,046,979 · 1
P01$1,263,194 · 2
R43$614,955 · 2
U54$487,640 · 2
Top collaborators
- Yi Zheng7 shared
- Carolyn M Lutzko4 shared
- Nicolas Nassar4 shared
- Donald B Kohn3 shared
- David A Williams3 shared
- Brittany De Kouchkovsky2 shared
- Hartmut Geiger1 shared
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularCellsSmall MoleculeSignal TransductionIn VivoBaseIn VitroMediatingGeneticTranslatingMalignant NeoplasmsPreventComplexTechnologyStem CellsGuanosine Triphosphate PhosphohydrolasesSignal PathwayGenesPre-ClinicalClinicPreparationCessation Of LifeProgenitorBiology
Grant awards (35)
Gene Delivery Core$97,526
U54 · FY2025 · DK · contact PI
Rho GTPase inhibitor for refrigerated platelet storage$1,188,244
R44 · FY2024 · HL
Mitochondria mediated intercellular metabolic coupling in bone marrow regeneration$150,000
R01 · FY2024 · DK · contact PI
Gene Delivery Core$97,526
U54 · FY2024 · DK · contact PI
Rho GTPase inhibitor for refrigerated platelet storage$858,735
R44 · FY2023 · HL
Mechanism of a novel approach for platelet cold storage$607,368
P01 · FY2023 · HL · contact PI
Targeted Inhibition in Leukemia$491,521
R01 · FY2023 · CA
Gene Delivery Core$97,526
U54 · FY2023 · DK · contact PI
Mechanism of a novel approach for platelet cold storage$655,826
P01 · FY2022 · HL · contact PI
Small molecules targeting RhoA for platelet cold storage in cancer care$635,494
R01 · FY2022 · HL
Targeted Inhibition in Leukemia$491,521
R01 · FY2022 · CA
Mitochondria mediated intercellular metabolic coupling in bone marrow regeneration$279,840
R01 · FY2022 · DK · contact PI
Gene Delivery Core$97,536
U54 · FY2022 · DK · contact PI
Small molecules targeting RhoA for platelet cold storage in cancer care$635,494
R01 · FY2021 · HL
Targeted Inhibition in Leukemia$465,554
R01 · FY2021 · CA
Mitochondria mediated intercellular metabolic coupling in bone marrow regeneration$279,840
R01 · FY2021 · DK · contact PI
Gene Delivery Core$97,526
U54 · FY2021 · DK · contact PI
Disseminating Curative Biological Therapies for Rare Pediatric Diseases$1,371,788
U01 · FY2020 · TR
Small molecules targeting RhoA for platelet cold storage in cancer care$635,494
R01 · FY2020 · HL
Targeted Inhibition in Leukemia$502,537
R01 · FY2020 · CA
Mitochondria mediated intercellular metabolic coupling in bone marrow regeneration$279,840
R01 · FY2020 · DK · contact PI
Disseminating Curative Biological Therapies for Rare Pediatric Diseases$1,357,953
U01 · FY2019 · TR
Small molecules targeting RhoA for platelet cold storage in cancer care$635,494
R01 · FY2019 · HL
Disseminating Curative Biological Therapies for Rare Pediatric Diseases$1,340,745
U01 · FY2018 · TR
G-CSF in Human Severe Congenital Neutropenia$308,100
R01 · FY2018 · GM · contact PI
G-CSF in Human Severe Congenital Neutropenia$308,100
R01 · FY2017 · GM · contact PI
G-CSF in Human Severe Congenital Neutropenia$308,100
R01 · FY2016 · GM · contact PI
G-CSF in Human Severe Congenital Neutropenia$308,100
R01 · FY2015 · GM · contact PI
Rho GTPase inhibitors for refrigerated platelet storage$224,700
R43 · FY2014 · HL · contact PI
Improving hematopoietic stem cell mobilization by the EGFR inhibitor Erlotinib$390,255
R43 · FY2012 · HL
Rac GTPase Inhibition in Chronic Myelogenous Leukemia$371,250
R01 · FY2012 · HL · contact PI
Rac GTPase Inhibition in Chronic Myelogenous Leukemia$375,000
R01 · FY2011 · HL · contact PI
Rac GTPase Inhibition in Chronic Myelogenous Leukemia$375,000
R01 · FY2010 · HL · contact PI
Rac GTPase Inhibition in Chronic Myelogenous Leukemia$375,000
R01 · FY2009 · HL · contact PI
Rac GTPase Inhibition in Chronic Myelogenous Leukemia$213,217
R01 · FY2009 · HL · contact PI